Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine pe...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pasteur Institute of Iran
2019-12-01
|
Series: | Vaccine Research |
Subjects: | |
Online Access: | http://vacres.pasteur.ac.ir/article-1-164-en.html |
id |
doaj-47eff60fb4864b699cbade5fc905ae04 |
---|---|
record_format |
Article |
spelling |
doaj-47eff60fb4864b699cbade5fc905ae042020-11-25T03:48:37ZengPasteur Institute of IranVaccine Research2383-28192423-49232019-12-016218Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobiumNada Abdel Aziz0Hatem Tallima1Marwa Abou El Dahab2Rashika El Ridi3 Faculty of SCience, Cairo University Faculty of Science, Cairo University Faculty of Science, Ein Shams University Zoology Department, Faculty of Science, Cairo University Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine peptidase, papain. Sterilizing immunity might, however, be induced if hamsters were vaccinated against S. haematobium infection with a homologous cysteine peptidase, i.e., S. haematobium cathepsin L (ShCL). Methods: Standards methods, techniques, and primers based on the published nucleotide sequence of ShCL were used to clone, amplify and express DNAs encoding the target enzyme in a bacterial expression vector. Repeat immunization trials were performed using recombinant ShCL alone or in combination with the vaccine candidate S. mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase, in parallel with S. mansoni lecucine aminopeptidase. Results: The results together indicated that our adjuvant-free, cysteine peptidase-based vaccine elicits highly significant (P < 0.0001) reduction in challenge worm burden and parasite egg viability. Protection was associated with whole blood cultures release of type 1, type 2, and type 17 cytokines, and modest, yet significant (P < 0.05) humoral response to ShCL. Conclusion: Sterilizing immunity was, however, not achieved in any trial, likely because of the preponderant role of cysteine peptidases-induced nonspecific factors in amplifying and antagonizing its protective potential. Experiments are planned in an aim to identify these elusive factors and their exact role.http://vacres.pasteur.ac.ir/article-1-164-en.htmlschistosoma haematobiumhamsterscysteine peptidasesvaccinerecombinant proteinsantibody response |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nada Abdel Aziz Hatem Tallima Marwa Abou El Dahab Rashika El Ridi |
spellingShingle |
Nada Abdel Aziz Hatem Tallima Marwa Abou El Dahab Rashika El Ridi Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium Vaccine Research schistosoma haematobium hamsters cysteine peptidases vaccine recombinant proteins antibody response |
author_facet |
Nada Abdel Aziz Hatem Tallima Marwa Abou El Dahab Rashika El Ridi |
author_sort |
Nada Abdel Aziz |
title |
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium |
title_short |
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium |
title_full |
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium |
title_fullStr |
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium |
title_full_unstemmed |
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium |
title_sort |
immunogenicity and protective capacity of schistosoma haematobium recombinant cathepsin l against infection of hamsters with s. haematobium |
publisher |
Pasteur Institute of Iran |
series |
Vaccine Research |
issn |
2383-2819 2423-4923 |
publishDate |
2019-12-01 |
description |
Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine peptidase, papain. Sterilizing immunity might, however, be induced if hamsters were vaccinated against S. haematobium infection with a homologous cysteine peptidase, i.e., S. haematobium cathepsin L (ShCL). Methods: Standards methods, techniques, and primers based on the published nucleotide sequence of ShCL were used to clone, amplify and express DNAs encoding the target enzyme in a bacterial expression vector. Repeat immunization trials were performed using recombinant ShCL alone or in combination with the vaccine candidate S. mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase, in parallel with S. mansoni lecucine aminopeptidase. Results: The results together indicated that our adjuvant-free, cysteine peptidase-based vaccine elicits highly significant (P < 0.0001) reduction in challenge worm burden and parasite egg viability. Protection was associated with whole blood cultures release of type 1, type 2, and type 17 cytokines, and modest, yet significant (P < 0.05) humoral response to ShCL. Conclusion: Sterilizing immunity was, however, not achieved in any trial, likely because of the preponderant role of cysteine peptidases-induced nonspecific factors in amplifying and antagonizing its protective potential. Experiments are planned in an aim to identify these elusive factors and their exact role. |
topic |
schistosoma haematobium hamsters cysteine peptidases vaccine recombinant proteins antibody response |
url |
http://vacres.pasteur.ac.ir/article-1-164-en.html |
work_keys_str_mv |
AT nadaabdelaziz immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium AT hatemtallima immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium AT marwaaboueldahab immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium AT rashikaelridi immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium |
_version_ |
1724498029211287552 |